Where fungal alpha-amylase is permitted, and what the file must show
Three markets, three routes. In the EU the governing instrument is Regulation (EC) No 1332/2008, but its Union list is not yet in force, so national rules fill the gap; in the United States the file rests on a GRAS position, a pre-1994 dietary ingredient basis or a processing-aid rationale; in Great Britain the assimilated EU regime runs through the Food Standards Agency. The paperwork differs by market. The questions a reviewer asks do not.
A food enzyme file is judged on the organism that made it, the carrier it sits on and the use it is authorised for; the SKB/g figure is only one line of it.
What counts as a food enzyme
Under Regulation (EC) No 1332/2008, a food enzyme is a product of plant, animal or microbial origin that carries one or more catalytically active enzymes and is added to food to perform a technological function. A preparation is that enzyme combined with additives or food ingredients used for storage, sale, standardisation, dilution or dissolution. The legal unit is therefore not "amylase" in the abstract but this strain, on this carrier, for this use.
That is why a change of strain, carrier or intended use restarts the assessment. The organism named here is Aspergillus oryzae, a filamentous fungus long used to produce food enzymes, and the strain designation is part of what a dossier identifies.
European Union: a list still in progress
Regulation (EC) No 1332/2008 provides the authorisation framework, Regulation (EC) No 1331/2008 the procedure, and Commission Regulation (EU) No 234/2011 the implementing detail. The Commission is assembling a Union list of authorised food enzymes; as of this review that list has not been adopted, so national provisions continue to apply under the transitional regime. Once the list is in force, only listed enzymes may be used for the listed purposes.
For that reason, "amylase is permitted in the EU" is too broad a statement to file. The workable question is which entry covers this preparation, from which strain, in which food and at what level — and the answer has to come from the current text, not from a supplier's summary written years ago.
Labelling follows the same regulation: a food enzyme sold to a manufacturer carries its name, a food-use statement, the activity and its unit, the lot and the storage conditions. Note also that Directive 2002/46/EC, which harmonises food supplements, lists vitamins and minerals rather than enzymes. A supplement label does not by itself make the enzyme lawful; that rests on the food enzyme or food ingredient route.
United States: three possible bases
There is no premarket approval list for food enzymes as such. A preparation can reach the market under a GRAS conclusion notified in a GRAS notice, or as a processing aid — present during manufacture without a technical effect in the finished food. A dietary supplement ingredient rests on one of the DSHEA bases: marketing before 1994, a new dietary ingredient notification, or a GRAS position.
The basis decides the label. Where the enzyme functions in the finished food it is an ingredient and is declared by common name under 21 CFR 101.4; where it qualifies as a processing aid at an insignificant level, 21 CFR 101.100(a)(3) exempts it. The supplier's basis belongs in the buyer's file, because the hazard analysis under 21 CFR 117 depends on it.
Two practical questions remain: whether the production strain is genetically modified, and whether the lead result triggers a California Proposition 65 warning. Documents answer both; the certificate alone does not.
Raw-material limits and finished-food exposure
The catalog sets Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg, with APC ≤10,000 cfu/g, yeast and mould ≤100 cfu/g, and E. coli and Salmonella absent. These are limits on the powder. The enforceable limits apply to the food as sold, and the link between them is the inclusion rate: at 0.05%, lead sitting at the 3 mg/kg limit contributes 1.5 µg/kg to the finished product.
| Parameter | Catalog figure | Legal anchor |
|---|---|---|
| Lead | ≤3 mg/kg | EU 2023/915, supplements: 3.0 mg/kg |
| Cadmium | ≤1 mg/kg | EU 2023/915, supplements: 1.0 mg/kg |
| Mercury | ≤0.1 mg/kg | EU 2023/915, supplements: 0.10 mg/kg |
| Arsenic | ≤2 mg/kg | No harmonised EU limit for supplements; buyer sets one |
| Microbiology | APC ≤10,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Finished-product specification, not a legal maximum |
Exposure is concentration multiplied by intake, so a compliant raw material can still be too much of a metal in a product with a high inclusion rate. The EU market note follows the contaminant instrument.
The boundary on the label
Enzyme activity is a technological parameter, not a nutrient amount: there is no reference intake and no daily value to declare against it. A label or a page may state that the product contains fungal alpha-amylase at a declared activity and that the enzyme serves a technological purpose in manufacture. It may not turn the activity into an effect on the person taking the product.
That rule holds for these pages too. No health, structure-function or disease-related claim is made for this enzyme; the editorial policy records the position.
Seven documents and their authors
| Document | Issuer | What it proves |
|---|---|---|
| Batch certificate | Manufacturer | Activity result, method, contaminants, lot |
| Specification sheet | Manufacturer | Release limits, unit definition, assay reference |
| Safety data sheet | Manufacturer | Hazards, dust controls, transport classification |
| Strain and source statement | Manufacturer | Species, strain designation, culture collection |
| GMO statement | Manufacturer | Whether the strain is modified |
| Allergen and carrier statement | Manufacturer | Carrier identity, fermentation residues |
| Authorisation or basis statement | Supplier or regulator | Union list entry, GRAS notice, processing-aid rationale or GB route |
Six questions for the file
Which strain, by designation? Which route or basis, with a reference? Which carrier? Which unit, defined by substrate and conditions? Which contaminant limits, by which method? Which label wording, in the language of the market? A file that answers those six can be reviewed quickly, and one that cannot will generate correspondence.
The strain and activity answers are worked through on the identity page; the pack and document flow on the MOQ page; market notes under US and UK; and the catalog specification on the amylase product page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation